Fasctrack
2 days ago
So for the gamblers and speculators out there, now is the time to double down. There is a small window until Q3 before unit sale revenues will be reported. After that, expect to chase the stock past .03. If Q4 then reports another 500k units, the stock could finally breakout and make a new high. If partnerships with any reputable pharmaceutical companies gets reported (as per the PR: "the company is exploring joint ventures with established pharmaceutical companies", coupled with the unit sales, look out. All IMHO.
Here Today
2 days ago
Well again and no disrespect, but going back to PR, you are incorrect. We will find out what the first shipments value to the company was as per the below excerpt from yesterdayβs PR:
βThe recent sale of 1 million units of its tetracycline-based topical antibiotic to Nigeria is not reflected in the financial results for Q2 2024. The first 500,000 units were shipped from the manufacturer in August 2024, with another 500,000 units scheduled for October 2024. The revenues from the August shipment will appear in the next quarterly report.β
Fdc4
2 days ago
Again, you are getting more confusing! I never said this to be sold individually or to consumers!!! Read again what I said. Next, again, he canβt put in the financial sheet a money that he doesnβt have on hand yet. See, it doesnβt work like that even though they settled a deal. So if you want to find out how much specifically was gained from this first shipment, you will need to reach Otiko himself, an insider or like I was trying to explain, once money is on hand, such results will be posted in the financialsβ¦.. The yearly one because in deals like this, overseas, it is given 1-2 months in order to properly distribute the product, etc. It is normally no paid on front. Knowing OTIKOβs delays, he isnβt going to put this on the quarter. He will add results on the year review
Fdc4
2 days ago
You got me confused by the way you are thinking. Not sure how are you expecting ViaDerma to provide you such numbers if the product hasnβt been sold in the market. See, we donβt know if it was provided to the government or private sector in Nigeria but either way, in those countries, normally you donβt get the check right away. You give 1-2 months!!! I used to work in the pharmaceutical industry overseas, I know a few things on these deals. Now, OTIKO definitely knows how much he will be making off the 500K shipment deal for sure but he canβt put such thoughts on a quarterly report without manifestation; otherwise he would be cooking the booksβ¦ You donβt want to be caught doing such. Anyways, I expect him to provide such results, including 2nd shipment, in the year review. He is always delayed on such and this time wonβt be different. Now, how much per item this will be sold? Definitely wonβt be less than $2 but I donβt expect it to be more $5 per bottle or item. If it would be in the states, yes, $30+ but in these countries, they wonβt over $10 dollars per bottle. ViaDerma is doing well with the license deals aloneβ¦ We are profitable with such, this will be multiple cents by Christmas for sure